Rat Per2/rPER2 ORF/cDNA clone-Adenovirus particle (NM_031678.2)

Cat. No.: vGMAD001699

Pre-made Rat Per2/rPER2 Adenovirus for Per2 overexpression in-vitro and in-vivo. The Per2 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified Per2-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAD001699 Rat Per2 Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAD001699
Gene Name Per2
Accession Number NM_031678.2
Gene ID 63840
Species Rat
Product Type Adenovirus particle (overexpression)
Insert Length 3774 bp
Gene Alias rPER2
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag Null
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGAATGGATATGTGGACTTTTCCCCAAGTCCCACCAGCCCCACCCAAGAGCCAGGGGAGCCTCAACCCACCCAGGCTGTGCTCCAGGAAGACGTGGACATGAGCAGCGGCTCCAGCGGAAATGAAAACTGCTCCACGGGGCGGGACTCTCAGGGCAGTGACTGTGACGACAGTGGAAAGGAGCTGCGGATGTTAGTGGAATCGTCCAACACTCACCCCAGCCCTGACGATACCTTCAGACTCATGATGACAGAGGCGGAGCATAACCCCTCCACAAGCGGCTGCAGTAGTGAGCAGTCTGCCAAAGCTGACGCACACAAAGAGCTGATAAGGACCCTGAGGGAGCTGAAGGTCCACCTCCCTGCAGACAAGAAGGCCAAGGGGAAGGCCAGCACGCTGGCAACCTTGAAGTACGCTCTGCGGAGCGTGAAGCAGGTGAAGGCTAATGAGGAGTACTACCAGCTGCTAATGTCCAGTGAGAGCCAGCCCTGCAGCGTGGATGTGCCTTCCTACACCATGGAGCAGGTTGAGGGCATTACCTCCGAGTATATTGTGAAGAACTCGGACATGTTTGCTGTGGCTGTGTCCCTGGTCTCTGGGAAGATCCTGTACATCTCCAACCAAGTCGCCCCCATCTTTCACTGTAAGAAGGACGCCTTCAGTGATGCCAAGTTTGTGGAGTTCCTGGCTCCCCATGACGTCAGTGTGTTCCACAGCTACACCACCCCTTACAAGCTTCCGCCCTGGAGTGTGAGCAGTGGCTTAGATTCTTTCACTCAGGAGTGCATGGAGGAGAAATCTTTTTTCTGCCGTGTCAGTGTTGGGAAACACCACGAGAATGAGATTCGCTACCAGCCCTTCCGCATGACACCCTACCTGGTCAAGGTGCAAGAGCAGAAGGGCGCTGCGAGCCAGCTCTGCTGCCTGCTGCTAGCAGAGAGGGTACACTCAGGCTATGAAGCTCCTAGAATTCCTCCCGAGAAGAGAATTTTCACAACAACCCACACACCAAACTGCCTGTTCCAGGATGTGGACGAAAGGGCGGTCCCCCTCCTGGGCTATCTACCTCAGGATCTGATCGAGACCCCTGTGCTCGTGCAGCTCCACCCCAGCGACCGGCCCTTGATGCTCGCCATCCACAAGAAGATCCTACAGGCCAGTGGGCAGCCTTTCGATTATTCTCCCATTCGATTCCGCACACGCAACGGGGAGTACATCACACTGGACACTAGCTGGTCCAGCTTCATCAACCCGTGGAGCAGGAAGATATCCTTCATCATCGGGAGGCACAAAGTCAGGGTAGGCCCTTTGAATGAGGATGTGTTCGCAGCCTCCCCTTGCCCAGAGGAGAAGACTCCGCACCCCAGCGTTCAGGAGCTCACAGAGCAAATCCACCGGCTACTGATGCAACCTGTCCCCCACAGCGGCTCCAGTGGCTATGGGAGCCTGGGCAGTAACGGATCCCACGAACACCTCATGAGCCAGACATCATCCAGCGACAGCAATGGTCAAGAGGAGTCTCACTGGAGGAGATCCGGAATTTTTAAAACCAGTGGCAAGAGTCAAAGCAAAAGTCACTTTTCTCCTGAGTCTGGAGGACAAAAGGAAGCCTCTGTTGCAGAAATGCAAAGTAGTCCTCCAGCTCAGGTGAGGTCTGTCACCACCATGGAAAGGGACAGCTCGGGGGCCAGCCTACCCAAGGCTAGCTTTCCAGAGGAACTAACCTATAAGAGCCAGCCTCCTTGCTCCTACCAGCAGATCAGCTGCCTGGACAGTGTCATCAGGTACCTGGAGAGCTGCAACGAGGCAGCCACCCTGAAAAGAAAGTGCGAGTTCCCAGCCAACATCCCATCCCGGAAGGCCACGGTCAGCCCTGGGCTGCACTCTGGAGAGGCAGCGCGGTCCTCCAAGGTGACCAGCCACACGGAGGTCAGTGCTCACTTGAGCTCCTTGGCGTTGCCGGGCAAGGCCGAGAGTGTGGTGTCCCTCACCAGCCAGTGCAGCTACAGCAGCACCATCGTGCACGTGGGCGACAAAAAGCCACAGCCTGAACTAGAGACAGTAGAAGATGTGGCCAGTGGGCCTGAGTCCCAGGATGATGCAGCTGGTGGCCTCAGCCAAGAAAAGGGGTCTCTGCAGAAGCTAGGCCTCACCAAGGAAGTTCTGGCTGCACATACCCAGAGAGAGGAACAGGGCTTCCTGCAGAGGTTCAGGGAAGTGAGCAGGCTCGGTGCCCTGCAGGCTCACTGCCAGAACTATCTCCAGGAGCGGTCCCGAGCCCCAGCAAGTGATCGAGGACTAAGAAATGCTTCTGGAATAGAATCATCTTGGAAAAAAACTGGAAAGAACAGGAAACTGAAGTCCAAGCGTGTCAAGACTCGAGACTCTTCTGAGAGCACAGGGTCTGGGGGACCCGTGTCCCACCGACCTCCCCTCGTGGGCCTGAATGCCACAGCCTGGTCGCCCTCTGACACATCCCAGTCTAGCTGTCCCTCTGCACCATTCCCTGCTCCAGTGCCAGCTTACCCACTACCTGTGTTCCCGGCACCTGGAATAGTATCCACACCAGGGACGGTGGTGGCACCACCTGCAGCCGCCCACACCGGCTTCACCATGCCTGTTGTGCCTATGGGCACCCAGCCTGAATTCGCAGTGCAGCCCCTGCCGTTCGCTGCCCCCTTGGCTCCGGTCATGGCCTTCATGCTACCCAGCTACCCGTTTCCACCAGCAACCCCAAACCTGCCTCAGGCCTTCTTCCCCAGCCAGCCTCACTTTCCGGCCCATCCCACACTTGCCTCTGAAATAACTCCTGCCTCCCAGGCTGAGTTCCCTAGTCGGACCTCGATGCTCAGGCAGCCATGTGCTTGCCCAGTCACCCCCCCGGCTGGCACAGTGGCCTTGGGCAGAGCCTCCCCGCCACTCTTCCAGTCCCGAGGCAGCAGTCCCCTACAGCTTAACCTGCTTCAGCTAGAGGAAGCACCTGAAAGTAGTACTGGAGCTGCAGGGACCTTGGGGACCACGGGGACAGCAGCTTCTGGTCTGGACTGCACATCTGGCGCATCTCGGGACCGGCAGCCAAAGGCACCTCCAACATGCAGTGAGCCCTCAGACACCCAGAACAGTGATGCCATCTCCACCTCCAGTGACCTGCTCAACCTCCTCCTGGGCGAGGACCTCTGCTCAGCCACCGGCTCAGCACTGTCGAGAAGCGGGGCATCTGCCACCTCAGACTCACTGGGCTCCAGCTCCCTGGGCTGTGACACATCCCGGAGTGGGGCAGGCAGCAGTGATACAAGTCACACCAGCAAATACTTTGGAAGCATTGACTCTTCAGAGAATAATCACAAAGCAAAAATGATCACAGACACGGAGGAGAGTGAACAGTTCATTAAGTACGTCTTGCAGGACCCCATCTGGCTGCTGATGGCCAACACAGACGACAATATCATGATGACATACCAGCTGCCCTCCCGGGATCTCCAGGCGGTCTTGAAAGAGGACCAGGAGAAGCTGAAGCTGCTGCAGAGGTCCCAGCCCCACTTCACGGAGGGCCAGAGGCGAGAGCTTCGAGAGGTTCATCCGTGGGTCCACACCGGGGGTCTGCCTACCGCCATCGACGTAACAGGGTGTGTTTACTGTGAAAGTGAGGAGAAAGGCAACCTTTGTCTGCCATATGAGGAAGACAGTCCTTCCCTGGGACTCTGTGATACCTCAGAAGCCAAAGAGGAGGAGAGCGGACAGCTGGCCAATCCTAGGAAGGAGGCCCAGACGTAA
ORF Protein Sequence MNGYVDFSPSPTSPTQEPGEPQPTQAVLQEDVDMSSGSSGNENCSTGRDSQGSDCDDSGKELRMLVESSNTHPSPDDTFRLMMTEAEHNPSTSGCSSEQSAKADAHKELIRTLRELKVHLPADKKAKGKASTLATLKYALRSVKQVKANEEYYQLLMSSESQPCSVDVPSYTMEQVEGITSEYIVKNSDMFAVAVSLVSGKILYISNQVAPIFHCKKDAFSDAKFVEFLAPHDVSVFHSYTTPYKLPPWSVSSGLDSFTQECMEEKSFFCRVSVGKHHENEIRYQPFRMTPYLVKVQEQKGAASQLCCLLLAERVHSGYEAPRIPPEKRIFTTTHTPNCLFQDVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQASGQPFDYSPIRFRTRNGEYITLDTSWSSFINPWSRKISFIIGRHKVRVGPLNEDVFAASPCPEEKTPHPSVQELTEQIHRLLMQPVPHSGSSGYGSLGSNGSHEHLMSQTSSSDSNGQEESHWRRSGIFKTSGKSQSKSHFSPESGGQKEASVAEMQSSPPAQVRSVTTMERDSSGASLPKASFPEELTYKSQPPCSYQQISCLDSVIRYLESCNEAATLKRKCEFPANIPSRKATVSPGLHSGEAARSSKVTSHTEVSAHLSSLALPGKAESVVSLTSQCSYSSTIVHVGDKKPQPELETVEDVASGPESQDDAAGGLSQEKGSLQKLGLTKEVLAAHTQREEQGFLQRFREVSRLGALQAHCQNYLQERSRAPASDRGLRNASGIESSWKKTGKNRKLKSKRVKTRDSSESTGSGGPVSHRPPLVGLNATAWSPSDTSQSSCPSAPFPAPVPAYPLPVFPAPGIVSTPGTVVAPPAAAHTGFTMPVVPMGTQPEFAVQPLPFAAPLAPVMAFMLPSYPFPPATPNLPQAFFPSQPHFPAHPTLASEITPASQAEFPSRTSMLRQPCACPVTPPAGTVALGRASPPLFQSRGSSPLQLNLLQLEEAPESSTGAAGTLGTTGTAASGLDCTSGASRDRQPKAPPTCSEPSDTQNSDAISTSSDLLNLLLGEDLCSATGSALSRSGASATSDSLGSSSLGCDTSRSGAGSSDTSHTSKYFGSIDSSENNHKAKMITDTEESEQFIKYVLQDPIWLLMANTDDNIMMTYQLPSRDLQAVLKEDQEKLKLLQRSQPHFTEGQRRELREVHPWVHTGGLPTAIDVTGCVYCESEEKGNLCLPYEEDSPSLGLCDTSEAKEEESGQLANPRKEAQT

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector pGMAD001699 Rat Per2 Adenovirus plasmid




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.